Cataloguing cancer genes may pay dividends.

A hunt through thousands of human genes has turned up nearly 200 that are altered in breast and colon cancer. These genes might be useful for diagnosing cancer or as new targets for drugs.

Read the story here.

Cataloguing cancer genes may pay dividends.

A hunt through thousands of human genes has turned up nearly 200 that are altered in breast and colon cancer. These genes might be useful for diagnosing cancer or as new targets for drugs.

Read the story here.